Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 436

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Caseins as source of bioactive peptides

Open access
Silva, Sofia V., Malcata, F.Xavier·2005·International Dairy Journal

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.idairyj.2004.04.009

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 107

  1. Addeo, 1992, Characterization of the 12% trichloroacetic acid-insoluble oligopeptides of Parmigiano–Reggiano cheese, Journal of Dairy Research, 59, 401, 10.1017/S0022029900030673 · DOI
  2. Ait-Oukhatar, 1999, Iron tissue storage and hemoglobin levels of deficient rats repleted with iron bound to the caseinophosphopeptide 1–25 of β-casein, Journal of Agricultural and Food Chemistry, 47, 2786, 10.1021/jf981018k · DOI
  3. Ait-Oukhatar, 2002, Bioavailability of caseinophosphopeptide-bound iron, Journal of Laboratory and Clinical Medicine, 140, 290, 10.1067/mlc.2002.128146 · DOI
  4. Brantl, 1979, Novel opioid peptides derived from casein (β-casomorphins), Hoppe Seyler's Zeitschrift fur Physiologische Chemie, 360, 1211, 10.1515/bchm2.1979.360.2.1211 · DOI · Paper page
  5. Bruck, 2003, A two-stage continuous culture system to study the effect of suplemental α-lactalbumin and glycomacropeptide on mixed cultures of human gut bacteria challenged with enteropathogenic Escherichia coli and Salmonella serotype typhimurium, Journal of Applied Microbiology, 95, 44, 10.1046/j.1365-2672.2003.01959.x · DOI
  6. Bruck, 2003, rRNA probes used to quantify the effects of glycomacropeptide and α-lactalbumin supplementation on the predominant groups of intestinal bacteria of infant rhesus monkeys challenged with enteropathogenic Escherichia coli, Journal of Pediatric Gastroenterology and Nutrition, 37, 273, 10.1097/00005176-200309000-00014 · DOI
  7. Chabance, 1995, Characterization of an antithrombotic peptide from κ-casein in new born plasma after milk ingestion, British Journal of Nutrition, 73, 583, 10.1079/BJN19950060 · DOI
  8. Chiba, 1989, Opioid antagonist peptides derived from κ-casein, Journal of Dairy Research, 56, 363, 10.1017/S0022029900028818 · DOI
  9. Clare, 2003, Biodefense properties of milk, Current Pharmaceutical Design, 9, 1239, 10.2174/1381612033454874 · DOI · Paper page
  10. Coste, 1992, Identification of C-terminal peptides from bovine β-casein that enhance proliferation of rat lymphocytes, Immunology Letters, 33, 41, 10.1016/0165-2478(92)90091-2 · DOI
  11. El-Salam, 1996, Characteristics and potential uses of the casein macropeptide, International Dairy Journal, 6, 327, 10.1016/0958-6946(95)00026-7 · DOI
  12. Ermisch, 1983, On the blood–brain barrier to peptides, Journal of Neurochemistry, 41, 1229, 10.1111/j.1471-4159.1983.tb00816.x · DOI
  13. Fanaro, 2002, [Protein quality and quantity in infant formulas. A critical look], Minerva Pediatrica, 54, 203
  14. Ferraretto, 2001, Casein phosphopeptides influence calcium uptake by cultured human intestinal HT-29 tumor cells, Journal of Nutrition, 131, 1655, 10.1093/jn/131.6.1655 · DOI
  15. Ferraretto, 2003, Casein-derived bioactive phosphopeptides, FEBS Letters, 551, 92, 10.1016/S0014-5793(03)00741-5 · DOI
  16. Fiat, 1993, Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunostimulating activities, Journal of Dairy Science, 76, 301, 10.3168/jds.S0022-0302(93)77351-8 · DOI · Paper page
  17. FitzGerald, 1998, Potential uses of caseinophosphopeptides, International Dairy Journal, 8, 451, 10.1016/S0958-6946(98)00068-5 · DOI · Paper page
  18. Florisa, 2003, Antibacterial and antivirial effects of milk proteins and derivatives thereof, Current Pharmaceutical Design, 9, 1257, 10.2174/1381612033454810 · DOI · Paper page
  19. Ganjam, 1997, Antiproliferative effects of yogurt fractions obtained by membrane dialysis on cultured mammalian intestinal cells, Journal of Dairy Science, 80, 2325, 10.3168/jds.S0022-0302(97)76183-6 · DOI
  20. Gentilucci, 2004, Recent advances in the investigation of the bioactive conformation of peptides active at the μ-opioid receptor. Conformational analysis of endomorphins, Current Topics in Medicinal Chemistry, 4, 105, 10.2174/1568026043451627 · doi:10.2174/1568026043451627
  21. Gómez-Ruiz, 2002, Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures, International Dairy Journal, 12, 697, 10.1016/S0958-6946(02)00059-6 · DOI · Paper page
  22. Haileselassie, 1999, Purification and identification of potentially bioactive peptides from enzyme-modified cheese, Journal of Dairy Science, 82, 1612, 10.3168/jds.S0022-0302(99)75389-0 · DOI
  23. Hamel, 1985, β-Casomorphin immunoreactive materials in cow's milk incubated with various bacterial species, Journal of Dairy Research, 52, 139, 10.1017/S0022029900023967 · DOI
  24. Hansen, 1997, Casein phosphopeptides improve zinc and calcium absorption from rice-based but not from whole grain infant cereal, Journal of Pediatric Gastroenterology and Nutrition, 24, 56, 10.1097/00005176-199701000-00014 · DOI
  25. Hata, 1999, Immunostimulatory action of a commercially available casein phosphopeptide preparation, CPP-III, in cell cultures, Milchwissenschaft, 54, 3
  26. Hata, 1996, A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects, American Journal of Clinical Nutrition, 64, 767, 10.1093/ajcn/64.5.767 · DOI · Paper page
  27. Hirayama, 1992, HPLC analysis of commercial casein phosphopeptides (CPP), Bioscience, Biotechnology and Biochemistry, 56, 1126, 10.1271/bbb.56.1126 · doi:10.1271/bbb.56.1126
  28. Janecka, 2004, Opioid receptors and their ligands, Current Topics in Medicinal Chemistry, 4, 1, 10.2174/1568026043451618 · DOI · Paper page
  29. Jollès, 1975, Structural aspects of the milk clotting process. Comparative features with the blood clotting process, Molecular and Cellular Biochemistry, 7, 73, 10.1007/BF01792075 · DOI
  30. Jollès, 1982, Comparison between the clotting of blood and milk, Trends in Biochemical Science, 7, 325, 10.1016/0968-0004(82)90264-X · DOI
  31. Jollès, 1986, Analogy between fibrinogen and casein, European Journal of Biochemistry, 158, 379
  32. Jollès, 1978, Structural relatedness of κ-casein and fibrinogen γ-chain, Journal of Molecular Evolution, 11, 271, 10.1007/BF01733837 · DOI
  33. Jollès, 1981, Immunostimulating substances from human casein, Journal of Immunopharmacology, 3, 363, 10.3109/08923978109031067 · DOI
  34. Karaki, 1990, Antihypertensive effect of tryptic hydrolysate of milk casein in spontaneously hypertensive rats, Comparative Biochemistry and Physiology C, 96, 367, 10.1016/0742-8413(90)90023-3 · DOI
  35. Kasai, 1992, Caseinophosphopeptides (CPP) in faeces of rats fed a casein diet, Bioscience, Biotechnology and Biochemistry, 56, 1150, 10.1271/bbb.56.1150 · DOI
  36. Kasai, 1995, Caseinophosphopeptides (CPP) in faeces and contents in digestive tract of rats fed casein and CPP preparations, Bioscience, Biotechnology and Biochemistry, 59, 26, 10.1271/bbb.59.26 · doi:10.1271/bbb.59.26
  37. Kelleher, 2003, Glycomacropeptide and α-lactalbumin supplementation of infant formula affects growth and nutritional status in infant rhesus monkeys, The American Journal of Clinical Nutrition, 77, 1261, 10.1093/ajcn/77.5.1261 · doi:10.1093/ajcn/77.5.1261
  38. Kilara, 2003, Peptides from milk proteins and their properties, Critical Reviews in Food Science and Nutrition, 43, 607, 10.1080/10408690390251138 · DOI
  39. Kitts, 2003, Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery, Current Pharmaceutical Design, 9, 1309, 10.2174/1381612033454883 · DOI · Paper page
  40. Kitts, 1994, Bioactive peptides in food, Canadian Journal of Physiology and Pharmacology, 72, 423, 10.1139/y94-062 · DOI
  41. Kohmura, 1990, Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human κ-casein, Agricultural and Biological Chemistry, 54, 835, 10.1271/bbb1961.54.835 · DOI
  42. Kohmura, 1989, Inhibition of angiotensin-converting enzyme by synthetic peptide fragments of human β-casein, Agricultural and Biological Chemistry, 53, 2107, 10.1271/bbb1961.53.2107 · doi:10.1271/bbb1961.53.2107
  43. Korhonen, 2003, Food-derived bioactive peptides—opportunites for designing future foods, Current Pharmaceutical Design, 9, 1297, 10.2174/1381612033454892 · DOI · Paper page
  44. Lahov, 1996, Antibacterial and immunostimulating casein-derived substances from milk, Food and Chemical Toxicology, 34, 131, 10.1016/0278-6915(95)00097-6 · DOI · Paper page
  45. Leclerc, 2002, Antihypertensive activity of casein-enriched milk fermented by Lactobacillus helveticus, International Dairy Journal, 12, 995, 10.1016/S0958-6946(02)00125-5 · DOI
  46. Longobardo, 2000, β-Casomorphin, Bioorganic and Medicinal Chemistry Letters, 10, 1185, 10.1016/S0960-894X(00)00187-6 · doi:10.1016/s0960-894x(00)00187-6
  47. Lonnerdal, 2003, Nutritional and physiologic significance of human milk proteins, The American Journal of Clinical Nutrition, 77, 1537, 10.1093/ajcn/77.6.1537S · DOI · Paper page
  48. Maeno, 1996, Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus Cp790, Journal of Dairy Science, 79, 1316, 10.3168/jds.S0022-0302(96)76487-1 · DOI · Paper page
  49. Maruyama, 1987, Angiotensin I-converting enzyme inhibitor activity of the C-terminal hexapeptide of αs1-casein, Agricultural and Biological Chemistry, 51, 2557, 10.1271/bbb1961.51.2557 · DOI
  50. Maruyama, 1987, Studies on the active site and antihypertensive activity of angiotensin I-converting enzyme inhibitors derived from casein, Agricultural and Biological Chemistry, 51, 1581, 10.1271/bbb1961.51.1581 · DOI
  51. Maruyama, 1982, A peptide inhibitor of angiotensin I-converting enzyme in the tryptic hydrolysate of casein, Agricultural and Biological Chemistry, 46, 1393, 10.1271/bbb1961.46.1393 · DOI
  52. Matar, 1996, β-Casomorphin 4 milk fermented by a mutant of Lactobacillus helveticus, International Dairy Journal, 6, 383, 10.1016/0958-6946(95)00015-1 · DOI
  53. Meisel, 1997, Biochemical properties of regulatory peptides derived from milk proteins, Biopolymers, 43, 119, 10.1002/(SICI)1097-0282(1997)43:2<119::AID-BIP4>3.0.CO;2-Y · DOI · Paper page
  54. Meisel, 1998, Overview on milk protein-derived peptides, International Dairy Journal, 8, 363, 10.1016/S0958-6946(98)00059-4 · DOI · Paper page
  55. Meisel, 1991, Heat-induced changes in casein-derived phosphopeptides, Zeitschrift für Ernaehrungswissenschaft, 30, 227, 10.1007/BF01610346 · doi:10.1007/bf01610346
  56. Meisel, 1989, Chemical characterization of bioactive peptides from in-vivo digestion of casein, Journal of Dairy Research, 56, 343, 10.1017/S0022029900028788 · DOI
  57. Meisel, 1989, Biologically active peptides in milk proteins, Zeitschrift für Ernaehrungswissenschaft, 28, 267, 10.1007/BF02019390 · DOI
  58. Meisel, 1997, ACE-inhibitory activities in milk products, Milchwissenschaft, 52, 307
  59. Meisel, 1998, Food proteins as precursors of peptide modulating human cell activity, Die Nahrung, 42, 175, 10.1002/(SICI)1521-3803(199808)42:03/04<175::AID-FOOD175>3.0.CO;2-R · doi:10.1002/(sici)1521-3803(199808)42:03/04<175::aid-food175>3.0.co;2-r
  60. Meisel, 1990, Milk proteins, Trends in Food Science and Technology, 1, 41, 10.1016/0924-2244(90)90029-X · DOI
  61. Meisel, 2003, Detection of caseinophosphopeptides in the distal ileostomy fluid of human subjects, British Journal of Nutrition, 89, 351, 10.1079/BJN2002803 · DOI
  62. Mellander, 1950, The physiological importance of the casein phosphopeptide calcium salts. 11. Peroral calcium dosage of infants, Acta of the Society of Medicine of Uppsala, 55, 247
  63. Migloire-Samour, 1988, Casein, a pro-hormone with immunomodulating role to the newborn?, Experientia, 44, 188, 10.1007/BF01941703 · DOI
  64. Minkiewicz, 2000, Identification of peptides obtained via hydrolysis of bovine casein by chymosin using HPLC and mass spectrometer, Milchwissenschaft, 55, 14
  65. Muehlenkamp, 1996, β-Casomorphins, cremoris. Journal of Dairy Science, 79, 20, 10.3168/jds.S0022-0302(96)76329-4 · DOI
  66. Mykkänen, 1980, Enhanced absorption of calcium by casein phosphopeptides in rachitis and normal chicks, The Journal of Nutrition, 110, 2141, 10.1093/jn/110.11.2141 · doi:10.1093/jn/110.11.2141
  67. Nakamura, 1995, Purification and characterization of angiotensin-I-converting enzyme inhibitors from sour milk, Journal of Dairy Science, 78, 777, 10.3168/jds.S0022-0302(95)76689-9 · DOI · Paper page
  68. Otani, 2000, The immunoenhancing property of a dietary casein phosphopeptide preparation in mice, Food and Agricultural Immunology, 12, 165, 10.1080/095401000404102 · DOI
  69. Parker, 1984, Immunostimulating hexapeptide from human casein, European Journal of Biochemistry, 145, 677, 10.1111/j.1432-1033.1984.tb08609.x · DOI · Paper page
  70. Pause, 1993, Comparative examination of anti-caries effect of cheese. II. Results and conclusions, Milchwissenschaft, 48, 137
  71. Pellegrino, 1997, Alkaline phosphate inactivation during Grana Padano cheese-making and related effects on cheese characterization and ripening, Le Lait, 77, 217, 10.1051/lait:1997215 · DOI · Paper page
  72. Pellegrini, 2003, Antimicrobial peptides from food proteins, Current Pharmaceutical Design, 9, 1225, 10.2174/1381612033454865 · DOI
  73. Peres, 1998, Improvement of zinc intestinal absorption and reduction of zinc/iron interaction using metal bound to the caseinophosphopeptide 1–25 of β-casein, Reproduction, Nutrition & Development, 38, 465, 10.1051/rnd:19980410 · DOI
  74. Perpetuo, 2003, Biochemical and pharmacological aspects of two bradykinin-potentiating peptides obtained from tryptic hydrolysis of casein, Journal of Protein Chemistry, 22, 601, 10.1023/B:JOPC.0000008724.98339.ff · DOI
  75. Petrilli, 1983, Primary structure of water buffalo β-casein tryptic and CNBr peptides, Italian Journal of Biochemistry, 32, 336
  76. Pihlanto-Leppälä, 1994, Opioid peptides produced by in vitro proteolysis of bovine caseins, International Dairy Journal, 41, 291, 10.1016/0958-6946(94)90028-0 · DOI
  77. Pihlanto, 2003, Bioactive peptides and proteins, Advances in Food and Nutrition Research, 47, 175, 10.1016/S1043-4526(03)47004-6 · DOI · Paper page
  78. Pihlanto-Leppälä, 1999, The effect of α-lactalbumin and β-lactoglobulin hydrolysates on the metabolic activity of Escherichia coli JM103, Journal of Applied Microbiology, 87, 540, 10.1046/j.1365-2672.1999.00849.x · DOI
  79. Pihlanto-Leppälä, 1998, Angiotensin I-converting enzyme inhibitory peptides derived from bovine milk proteins, International Dairy Journal, 8, 325, 10.1016/S0958-6946(98)00048-X · DOI · Paper page
  80. Recio, 1999, Identification of two distinct antibacterial domains within the sequence of bovine αs2-casein, Biochimica et Biophysica Acta, 1428, 314, 10.1016/S0304-4165(99)00079-3 · DOI
  81. Reynolds, 1987, The prevention of surface demineralisation of bovine enamel and change in plaque composition by casein in intra-oral model, Journal of Dental Research, 66, 1120, 10.1177/00220345870660060601 · DOI · Paper page
  82. Reynolds, 1994, A selective purification procedure for multiple phosphoseryl-containing peptides and methods for their identification, Analytical Biochemistry, 217, 277, 10.1006/abio.1994.1119 · DOI
  83. Richardson, 1979, The primary structure of the bovine β-caseins, European Journal of Biochemistry, 99, 285, 10.1111/j.1432-1033.1979.tb13255.x · DOI
  84. Rigo, 2001, An infant formula free of glycomacropeptide prevents hypothreoninemia in infant formula-fed preterm infants, Journal of Pediatric Gastroenterology and Nutrition, 32, 127, 10.1097/00005176-200102000-00006 · doi:10.1097/00005176-200102000-00006
  85. Roudot-Algaron, 1994, Phosphopeptides from Comté cheese, Journal of Food Science, 59, 544, 10.1111/j.1365-2621.1994.tb05558.x · DOI
  86. Ryhänen, 2001, A new type of ripened, low-fat cheese with bioactive properties, International Dairy Journal, 11, 441, 10.1016/S0958-6946(01)00079-6 · DOI · Paper page
  87. Saito, 2000, Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese, Journal of Dairy Science, 83, 1434, 10.3168/jds.S0022-0302(00)75013-2 · DOI · Paper page
  88. Sandre, 2001, A peptide derived from bovine β-casein modulates functional properties of bone marrow-derived macrophages from germfree and human flora-associated mice, The Journal of Nutrition, 131, 2936, 10.1093/jn/131.11.2936 · DOI
  89. Sato, 1986, Casein phosphopeptide (CPP) enhances calcium absorption from the ligated segment of rat small intestine, Journal of Nutritional Science and Vitaminology, 32, 67, 10.3177/jnsv.32.67 · DOI · Paper page
  90. Schlimme, 1995, Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects, Die Nahrung, 39, 1, 10.1002/food.19950390102 · DOI
  91. Shah, 2000, Effects of milk-derived bioactives, British Journal of Nutrition, 84, S3, 10.1017/S000711450000218X · DOI · Paper page
  92. Smacchi, 1998, Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria, Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme, Enzyme and Microbial Technology, 22, 687, 10.1016/S0141-0229(97)00261-5 · DOI
  93. Smacchi, 2000, Bioactive peptides in dairy products, Food Microbiology, 17, 129, 10.1006/fmic.1999.0302 · DOI
  94. Stan, 1988, Heterogeneity and physiological activity of bovine κ-casein proteolysis products, Voprosy Pitaniia, 1, 39
  95. Sturner, 1988, Opioid peptide content in infant formulas, Pediatric Research, 23, 4
  96. Sun, 2003, Relation of β-casomorphin to apnea in sudden infant death syndrome, Peptides, 24, 937, 10.1016/S0196-9781(03)00156-6 · DOI
  97. Svedberg, 1985, Demonstration of a β-casomorphin immunoreactive material in in vivo digest of bovine milk and in small intestine contents after bovine milk ingestion in adult humans, Peptides, 6, 825, 10.1016/0196-9781(85)90308-0 · DOI · Paper page
  98. Tauzin, 2002, Angiotensin-I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine αs2-casein, FEBS Letters, 531, 369, 10.1016/S0014-5793(02)03576-7 · DOI
  99. Teschemacher, 2003, Opioid receptor ligands derived from food proteins, Current Pharmaceutical Design, 9, 1331, 10.2174/1381612033454856 · DOI
  100. Teschemacher, 1997, Milk protein-derived opioid receptor ligands, Biopolymers, 43, 99, 10.1002/(SICI)1097-0282(1997)43:2<99::AID-BIP3>3.0.CO;2-V · DOI
  101. Tirelli, 1997, Bioactive peptides in milk products, Italian Journal of Food Science, 9, 91
  102. Tomita, 1994, A review, Acta Paediatrica Japonica, 36, 585, 10.1111/j.1442-200X.1994.tb03250.x · DOI
  103. Wal, 2002, Cow's milk proteins/allergens, Annals of Allergy, Asthma & Immunology, 89, 3, 10.1016/S1081-1206(10)62115-1 · DOI · Paper page
  104. Walker-Smith, 2003, Hypoallergenic formulas, Annals of Allergy, Asthma & Immunology, 90, 112, 10.1016/S1081-1206(10)61671-7 · doi:10.1016/s1081-1206(10)61671-7
  105. Xu, 1998, Bioactive peptides in milk and their biological and health implications, Food Reviews International, 14, 1, 10.1080/87559129809541147 · DOI
  106. Yamamoto, 1994, Antihypertensive effects of different kinds of fermented milk in spontaneously hypertensive rats, Bioscience, Biotechnology and Biochemistry, 58, 776, 10.1271/bbb.58.776 · DOI
  107. Zhang, 1998, Study on immunologic regulation action of Ru Zhen, China Dairy Industry, 26, 26

Cited by

See all 436

Metadata

Authors
Silva, S. V., & Malcata, F. X.
Venue
International Dairy Journal
Publisher
Elsevier BV
Published
2005-01
Volume
15
Issue
1
Pages
1-15
ISSN
0958-6946 (ISSN-L)
OpenAlex
W2012924910
Cited by
436
References
16
FWCI
5.14
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Caseins as source of bioactive peptides. https://app.cochat.ai/papers/10.1016/j.idairyj.2004.04.009
The paper
Silva, S. V., & Malcata, F. X. (2005). Caseins as source of bioactive peptides. International Dairy Journal. https://doi.org/10.1016/j.idairyj.2004.04.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.